Zhang B, Zhang Z, Gao J, Lu S, Pang R, Li D
iScience. 2025; 28(3):111536.
PMID: 40040813
PMC: 11879607.
DOI: 10.1016/j.isci.2024.111536.
Liao T, Chen X, Qiu F, Zhang X, Wu F, Zhao Z
J Nanobiotechnology. 2025; 23(1):166.
PMID: 40038745
PMC: 11877876.
DOI: 10.1186/s12951-025-03217-0.
Zahoor A, Khazer R, Mehraj I, Gani U, Fayaz F, Khanday F
Funct Integr Genomics. 2025; 25(1):50.
PMID: 40024973
DOI: 10.1007/s10142-025-01552-x.
Horenstein A, Faini A, Morandi F, Ortolan E, Storti P, Giuliani N
Front Immunol. 2025; 16:1519300.
PMID: 40013150
PMC: 11860881.
DOI: 10.3389/fimmu.2025.1519300.
Sherpally D, Manne A
Cancers (Basel). 2025; 17(4).
PMID: 40002184
PMC: 11853216.
DOI: 10.3390/cancers17040589.
Glioblastoma Cell Migration, Invasion and Vasculogenic Mimicry Downmodulated by Novel uPAcyclin Derivatives.
Santoro F, Merlino F, Brancaccio D, Camerino I, Belli S, Cimmino A
Cells. 2025; 14(4).
PMID: 39996732
PMC: 11853379.
DOI: 10.3390/cells14040259.
The extracellular matrix protein type I collagen and fibronectin are regulated by β-arrestin-1/endothelin axis in human ovarian fibroblasts.
Masi I, Ottavi F, Caprara V, Rio D, Kunkl M, Spadaro F
J Exp Clin Cancer Res. 2025; 44(1):64.
PMID: 39985042
PMC: 11844176.
DOI: 10.1186/s13046-025-03327-5.
pH of Microenvironment Directly Modulates the Phenotype and Function of Cancer-Associated Fibroblasts.
Li Y, He C, Shen A, Wang Y, Xu Z, Zhang L
ACS Omega. 2025; 10(4):3937-3943.
PMID: 39926491
PMC: 11799978.
DOI: 10.1021/acsomega.4c09716.
Integrated Analysis of Bulk RNA Sequencing, eQTL, GWAS, and Single-Cell RNA Sequencing Reveals Key Genes in Hepatocellular Carcinoma.
Gong M, Zhao X, Li Q, Hao Q, Cha L, Dong G
J Cell Mol Med. 2025; 29(2):e70359.
PMID: 39853609
PMC: 11756993.
DOI: 10.1111/jcmm.70359.
The Immune Landscape and Its Potential for Immunotherapy in Advanced Biliary Tract Cancer.
Santoso A, Levink I, Pihlak R, Chau I
Curr Oncol. 2025; 32(1).
PMID: 39851940
PMC: 11763487.
DOI: 10.3390/curroncol32010024.
Advancing precision cancer immunotherapy drug development, administration, and response prediction with AI-enabled Raman spectroscopy.
Chadokiya J, Chang K, Sharma S, Hu J, Lill J, Dionne J
Front Immunol. 2025; 15():1520860.
PMID: 39850874
PMC: 11753970.
DOI: 10.3389/fimmu.2024.1520860.
The tumour histopathology "glossary" for AI developers.
Mandal S, Baker A, Graham T, Brautigam K
PLoS Comput Biol. 2025; 21(1):e1012708.
PMID: 39847582
PMC: 11756763.
DOI: 10.1371/journal.pcbi.1012708.
The tumor immune microenvironment in primary cutaneous melanoma.
Zilberg C, Ferguson A, Lyons J, Gupta R, Damian D
Arch Dermatol Res. 2025; 317(1):273.
PMID: 39825956
PMC: 11742903.
DOI: 10.1007/s00403-024-03758-8.
Spatial profiling of endoplasmic reticulum stress markers in tumor associated cells predicts patient outcomes in pancreatic cancer.
Porter G, Norris M, Apte M, Merlot A
Neoplasia. 2025; 60:101115.
PMID: 39818177
PMC: 11786694.
DOI: 10.1016/j.neo.2024.101115.
Drug Delivery System Targeting Cancer-Associated Fibroblast for Improving Immunotherapy.
Zhang Z, Wang R, Chen L
Int J Nanomedicine. 2025; 20():483-503.
PMID: 39816375
PMC: 11734509.
DOI: 10.2147/IJN.S500591.
Gene expression dynamics in fibroblasts during early-stage murine pancreatic carcinogenesis.
Ohri N, Haussler J, Javakhishvili N, Vieweg D, Zourelidis A, Trojanowicz B
iScience. 2025; 28(1):111572.
PMID: 39811640
PMC: 11731286.
DOI: 10.1016/j.isci.2024.111572.
Single-cell transcriptomics unveils multifaceted immune heterogeneity in early-onset versus late-onset cervical cancer.
Chen Q, Deng D, Zhu H, Li S
World J Surg Oncol. 2025; 23(1):12.
PMID: 39810181
PMC: 11730844.
DOI: 10.1186/s12957-025-03654-z.
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.
Glaviano A, Lau H, Carter L, Lee E, Lam H, Okina E
J Hematol Oncol. 2025; 18(1):6.
PMID: 39806516
PMC: 11733683.
DOI: 10.1186/s13045-024-01634-6.
Ovarian tumor microenvironment contributes to tumor progression and chemoresistance.
Ponton-Almodovar A, Sanderson S, Rattan R, Bernard J, Horibata S
Cancer Drug Resist. 2025; 7():53.
PMID: 39802952
PMC: 11724355.
DOI: 10.20517/cdr.2024.111.
Targeting Pancreatic Cancer Cell Stemness by Blocking Fibronectin-Binding Integrins on Cancer-Associated Fibroblasts.
Wu C, Von Schalscha T, Sansanwal D, Qian C, Jiang Q, Shepard R
Cancer Res Commun. 2025; 5(1):195-208.
PMID: 39785683
PMC: 11783622.
DOI: 10.1158/2767-9764.CRC-24-0491.